Precision oncology relies on targeted drugs, such as kinase inhibitors, that are presently administered based on molecular profiles obtained from surgical or bioptic tissue samples. The inherent ability of human tumors to molecularly evolve in response to drug pressures represents a daunting diagnostic challenge. Circulating free DNA (cfDNA) released from primary and metastatic lesions can be used to draw molecular maps that can be continuously updated to match each tumor's evolution. We will present evidence that liquid biopsies can effectively interrogate how targeted therapies drive lesion-specific drug-resistance mechanisms. The impact of drug-induced molecular heterogeneity on subsequent lines of treatment will also be discussed.

Lesion-Directed Therapies and Monitoring Tumor Evolution Using Liquid Biopsies

RUSSO, MARIANGELA;BARDELLI, Alberto
2017

Abstract

Precision oncology relies on targeted drugs, such as kinase inhibitors, that are presently administered based on molecular profiles obtained from surgical or bioptic tissue samples. The inherent ability of human tumors to molecularly evolve in response to drug pressures represents a daunting diagnostic challenge. Circulating free DNA (cfDNA) released from primary and metastatic lesions can be used to draw molecular maps that can be continuously updated to match each tumor's evolution. We will present evidence that liquid biopsies can effectively interrogate how targeted therapies drive lesion-specific drug-resistance mechanisms. The impact of drug-induced molecular heterogeneity on subsequent lines of treatment will also be discussed.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE
7
2
a029587
0
http://perspectivesinmedicine.cshlp.org/content/early/2016/12/21/cshperspect.a029587.long
CELL LUNG-CANCER; INHIBITOR RESISTANCE MECHANISMS; METASTATIC COLORECTAL-CANCER; ACQUIRED-RESISTANCE; CLONAL EVOLUTION; BREAST-CANCER; PLASMA DNA; INTRATUMOR HETEROGENEITY; BRANCHED EVOLUTION; CARCINOMA PATIENTS
Russo, Mariangela; Bardelli, Alberto
File in questo prodotto:
File Dimensione Formato  
2016-Lesion-Directed Therapies.pdf

non disponibili

Tipo di file: PDF EDITORIALE
Dimensione 904.81 kB
Formato Adobe PDF
904.81 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1622761
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact